The Medicines and Healthcare products Regulatory Agency (MHRA) leads the annual #MedSafetyWeek campaign to enhance patient safety by encouraging the reporting of suspected side effects from medicines and adverse incidents involving medical devices. In 2024, the ninth #MedSafetyWeek took place from 4 to 10 November, focusing on 'preventing side effects' and emphasising the importance of using healthcare products correctly to minimise harm.

This global initiative saw participation from regulators in 94 countries and 107 organisations, all collaborating to raise awareness about the significance of reporting adverse reactions. The campaign highlighted that preventable side effects contribute significantly to patient and healthcare service burdens, with studies indicating that between one-third and half of all adverse drug reactions (ADRs) may be preventable.

The MHRA's Yellow Card scheme plays a crucial role in this effort by collecting reports of suspected side effects and adverse incidents. These reports help identify new safety information and ensure that medicines and medical devices are used as safely as possible. Healthcare professionals, patients, and carers are all encouraged to report any suspicions, as even a single report can contribute to improving overall patient safety.

During #MedSafetyWeek, the MHRA provided various resources, including digital posters, social media banners, and e-learning modules, to support the campaign and encourage widespread participation. By promoting the correct use of medicines and medical devices and the prompt reporting of any issues, the campaign aims to reduce preventable side effects and enhance patient safety across the UK and beyond.